ArticleOncotarget2017

Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway.

Huijuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.